Your browser doesn't support javascript.
loading
Continued treatment with secukinumab is associated with high retention or regain of response.
Augustin, M; Thaci, D; Eyerich, K; Pinter, A; Radtke, M; Lauffer, F; Mrowietz, U; Gerdes, S; Pariser, D; Lebwohl, M; Sieder, C; Melzer, N; Reich, K.
Afiliação
  • Augustin M; Institute of Health Services Research in Dermatology and Nursing, University Medical Center of Hamburg Eppendorf, Germany.
  • Thaci D; Comprehensive Centre of Inflammation Medicine, University of Lübeck, Lübeck, Germany.
  • Eyerich K; Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany.
  • Pinter A; University Hospital Frankfurt, Frankfurt am Main, Germany.
  • Radtke M; Institute of Health Services Research in Dermatology and Nursing, University Medical Center of Hamburg Eppendorf, Germany.
  • Lauffer F; Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany.
  • Mrowietz U; Psoriasis-Center, Department of Dermatology, University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Gerdes S; Psoriasis-Center, Department of Dermatology, University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Pariser D; Eastern Virginia Medical School and Virginia Clinical Research, Inc., Norfolk, VA, U.S.A.
  • Lebwohl M; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, U.S.A.
  • Sieder C; Novartis Pharma GmbH, Nürnberg, Germany.
  • Melzer N; Novartis Pharma GmbH, Nürnberg, Germany.
  • Reich K; Dermatologikum Berlin and SCIderm Research Institute, Hamburg, Germany.
Br J Dermatol ; 182(1): 67-75, 2020 01.
Article em En | MEDLINE | ID: mdl-30972746
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Anticorpos Monoclonais Humanizados Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Humans Idioma: En Revista: Br J Dermatol Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Anticorpos Monoclonais Humanizados Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Humans Idioma: En Revista: Br J Dermatol Ano de publicação: 2020 Tipo de documento: Article